Shares of Plexus Corp. (NASDAQ:PLXS – Get Free Report) have earned an average recommendation of “Moderate Buy” from the five ratings firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $152.00.
Several equities research analysts recently commented on PLXS shares. Sidoti upgraded shares of Plexus from a “neutral” rating to a “buy” rating and upped their price target for the company from $135.00 to $150.00 in a research report on Friday, July 25th. Benchmark restated a “buy” rating and issued a $160.00 price target on shares of Plexus in a research report on Wednesday, June 4th. Needham & Company LLC reduced their price target on shares of Plexus from $162.00 to $158.00 and set a “buy” rating for the company in a research report on Thursday, July 24th. Wall Street Zen downgraded shares of Plexus from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 16th. Finally, Stifel Nicolaus set a $140.00 price target on shares of Plexus in a research report on Thursday, July 24th.
View Our Latest Stock Analysis on PLXS
Insider Buying and Selling
Institutional Investors Weigh In On Plexus
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Huntington National Bank lifted its position in Plexus by 41.5% in the 2nd quarter. Huntington National Bank now owns 324 shares of the technology company’s stock worth $44,000 after buying an additional 95 shares in the last quarter. Xponance Inc. increased its stake in shares of Plexus by 4.8% during the 1st quarter. Xponance Inc. now owns 2,315 shares of the technology company’s stock worth $297,000 after purchasing an additional 106 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its stake in shares of Plexus by 7.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,750 shares of the technology company’s stock worth $237,000 after purchasing an additional 116 shares during the last quarter. Inspire Investing LLC increased its stake in shares of Plexus by 4.8% during the 1st quarter. Inspire Investing LLC now owns 2,682 shares of the technology company’s stock worth $344,000 after purchasing an additional 123 shares during the last quarter. Finally, Yousif Capital Management LLC increased its stake in shares of Plexus by 1.2% during the 2nd quarter. Yousif Capital Management LLC now owns 10,117 shares of the technology company’s stock worth $1,369,000 after purchasing an additional 124 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company’s stock.
Plexus Stock Down 0.4%
PLXS stock opened at $137.51 on Friday. Plexus has a 12 month low of $103.43 and a 12 month high of $172.89. The firm has a market cap of $3.71 billion, a PE ratio of 23.43 and a beta of 0.82. The firm has a 50 day simple moving average of $133.30 and a 200 day simple moving average of $129.94. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.58 and a quick ratio of 0.74.
Plexus (NASDAQ:PLXS – Get Free Report) last released its earnings results on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, beating the consensus estimate of $1.71 by $0.19. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The business’s quarterly revenue was up 6.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.45 earnings per share. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. Equities research analysts forecast that Plexus will post 5.9 earnings per share for the current fiscal year.
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Further Reading
- Five stocks we like better than Plexus
- 10 Best Airline Stocks to Buy
- Reddit Hits Record Highs: Why Wall Street Is Taking Notice
- What is Short Interest? How to Use It
- After a Strong Wall Street Debut, Klarna’s Real Work Begins
- 3 Healthcare Dividend Stocks to Buy
- 3 Dividend Growers That Fly Under the Radar
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.